{"product_id":"cbd-isbn-9780262544054","title":"CBD","description":"\u003cb\u003eA comprehensive review of the scientific literature on the possible benefits of CBD, describing findings from both preclinical and human clinical studies.\u003c\/b\u003e\u003cbr\u003e\u003cbr\u003eCBD (cannabidiol), a nonintoxicating compound derived from the cannabis plant, can be found in products ranging from lotion and smoothies to chewable gummies and pet treats. It’s been promoted—but not always scientifically validated—as a treatment for medical conditions including psychosis, anxiety, pain, and even cancer. This book by three leading cannabis researchers looks at the science of CBD. It offers a comprehensive review of the scientific literature on the possible benefits of CBD, describing findings from both preclinical and human clinical studies. \u003cbr\u003e \u003cbr\u003eThe authors report that the current CBD fad has some basis in preclinical animal research that indicates potential beneficial effects. Clinical studies, hampered by regulations governing research with cannabis, have lagged behind the basic animal research. The authors examine what research shows about chemical and pharmacological aspects of CBD and CBD’s interaction with THC, the main psychotropic compound found in cannabis. They go on to review current state of knowledge about CBD’s effectiveness in treating epilepsy, cancer, nausea, pain, anxiety, PTSD, depression, sleep disorders, psychosis, and addiction.\u003cbr\u003e Preface vii\u003cbr\u003e1 Introduction 1\u003cbr\u003e2 Chemical and Pharmacological Aspects 11\u003cbr\u003e3 CBD\/THC Interactions 39\u003cbr\u003e4 Epilepsy 53\u003cbr\u003e5 Neuroprotection, Tissue Protection, and Cancer 63\u003cbr\u003e6 Nausea, Vomiting, and Appetite 97\u003cbr\u003e7 Pain and Inflammation 117\u003cbr\u003e8 Anxiety 149\u003cbr\u003e9 PTSD, Depression and Sleep 163\u003cbr\u003e10 Psychosis and Schizophrenia 181\u003cbr\u003e11 Addiction 195\u003cbr\u003e12 Conclusion 207\u003cbr\u003eReferences 221\u003cbr\u003eIndex 301CBD is a topic surrounded by anecdote and hype, but this book offers an accessible, timely and even-handed evaluation of evidence. Without overselling or pushing a particular agenda (problems that are rife in the cannabis field), the book raises critical scientific issues and is an important and interesting contribution to the literature.\u003cbr\u003e \u003cb\u003e—Margaret Haney, Director of the Cannabis Research Laboratory and Professor of Neurobiology at the Columbia University Irving Medical Center\u003c\/b\u003e\u003cbr\u003e \u003cbr\u003eCannabinoid science is novel and the market has grown at a faster rate than research and regulation. This book provides a comprehensive, fact-based summary that is desperately needed by consumers, patients, practitioners, and policy makers to inform important decisions.\u003cbr\u003e \u003cb\u003e—Shawn Hauser, Partner, Vicente Sederberg LLP\u003c\/b\u003eLinda A. Parker is Professor Emeritus in the Psychology and Collaborative Neuroscience Program at the University of Guelph and the author of \u003ci\u003eCannabinoids and the Brain\u003c\/i\u003e (MIT Press).\u003cbr\u003e \u003cbr\u003eErin M. Rock is a Postdoctoral Fellow and Adjunct Faculty member in the Psychology and Collaborative Neuroscience Program at the University of Guelph. \u003cbr\u003e \u003cbr\u003eRaphael Mechoulam, often called “the father of cannabis research,” is Lionel Jacobson Professor of Medicinal Chemistry at Hebrew University and winner of the 2019 Harvey Prize for outstanding contributions to science and technology.\u003cbr\u003e ","brand":"The MIT Press","offers":[{"title":"Default Title","offer_id":46303666995429,"sku":"NP9780262544054","price":30.0,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1842\/7735\/files\/9780262544054.jpg?v=1767723510","url":"https:\/\/k12savings.com\/es\/products\/cbd-isbn-9780262544054","provider":"K12savings","version":"1.0","type":"link"}